1. Home
  2. NRXS vs SMTK Comparison

NRXS vs SMTK Comparison

Compare NRXS & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXS
  • SMTK
  • Stock Information
  • Founded
  • NRXS 2011
  • SMTK 2009
  • Country
  • NRXS United States
  • SMTK United Kingdom
  • Employees
  • NRXS N/A
  • SMTK N/A
  • Industry
  • NRXS
  • SMTK
  • Sector
  • NRXS
  • SMTK
  • Exchange
  • NRXS Nasdaq
  • SMTK NYSE
  • Market Cap
  • NRXS 13.0M
  • SMTK 13.3M
  • IPO Year
  • NRXS 2023
  • SMTK N/A
  • Fundamental
  • Price
  • NRXS $2.60
  • SMTK $1.34
  • Analyst Decision
  • NRXS
  • SMTK
  • Analyst Count
  • NRXS 0
  • SMTK 0
  • Target Price
  • NRXS N/A
  • SMTK N/A
  • AVG Volume (30 Days)
  • NRXS 4.9M
  • SMTK 94.4K
  • Earning Date
  • NRXS 05-12-2025
  • SMTK 05-13-2025
  • Dividend Yield
  • NRXS N/A
  • SMTK N/A
  • EPS Growth
  • NRXS N/A
  • SMTK N/A
  • EPS
  • NRXS N/A
  • SMTK N/A
  • Revenue
  • NRXS $2,934,945.00
  • SMTK $105,000.00
  • Revenue This Year
  • NRXS $138,883.78
  • SMTK N/A
  • Revenue Next Year
  • NRXS $118.59
  • SMTK N/A
  • P/E Ratio
  • NRXS N/A
  • SMTK N/A
  • Revenue Growth
  • NRXS 27.52
  • SMTK 854.54
  • 52 Week Low
  • NRXS $1.33
  • SMTK $1.00
  • 52 Week High
  • NRXS $6.20
  • SMTK $8.16
  • Technical
  • Relative Strength Index (RSI)
  • NRXS 50.26
  • SMTK N/A
  • Support Level
  • NRXS $2.59
  • SMTK N/A
  • Resistance Level
  • NRXS $2.82
  • SMTK N/A
  • Average True Range (ATR)
  • NRXS 0.46
  • SMTK 0.00
  • MACD
  • NRXS -0.04
  • SMTK 0.00
  • Stochastic Oscillator
  • NRXS 12.83
  • SMTK 0.00

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

About SMTK SMARTKEM INC

SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.

Share on Social Networks: